A Scalable Synthesis of an Azabicyclooctanyl Derivative, a Novel DPP-4 Inhibitor

A practical synthetic strategy to a chiral azabicycclooctanyl derivative (1), a potent DPP-4 inhibitor, starting from a commercially available nortropine is described. The stereogenic center of 1 was established employing a modified protocol of Ellman’s diastereoselective addition of a benzylic nucl...

Full description

Saved in:
Bibliographic Details
Published inJournal of organic chemistry Vol. 73; no. 22; pp. 9016 - 9021
Main Authors Fei, Zhongbo, Wu, Quanbing, Zhang, Fei, Cao, Yudong, Liu, Chuanqin, Shieh, Wen-Chung, Xue, Song, McKenna, Joe, Prasad, Kapa, Prashad, Mahavir, Baeschlin, Daniel, Namoto, Kenji
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 21.11.2008
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A practical synthetic strategy to a chiral azabicycclooctanyl derivative (1), a potent DPP-4 inhibitor, starting from a commercially available nortropine is described. The stereogenic center of 1 was established employing a modified protocol of Ellman’s diastereoselective addition of a benzylic nucleophile to tert-butanesulfinimine. Other key steps include Corey−Chaykovsky reaction, Meinwald rearrangement, and CDMT-promoted amide bond formation involving a sterically hindered amine 2.
Bibliography:Experimental details for the syntheses of compounds 7 and 11 and copies of 1H and 13C NMR spectra for compounds 1, 7, 9, 11, 12, 15, 17a, 17b, 18, and 20, and HPLC spectra for compound 18. This material is available free of charge via the Internet at http://pubs.acs.org.
istex:9ADADAAC92A53ACD845B0E4EA60159BDEF51F94B
ark:/67375/TPS-B9F6SG2P-B
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3263
1520-6904
DOI:10.1021/jo801830x